Home - Huayi Partners

huayi partners

Huayi 华医 Partners is a privately owned venture capital firm based in China and North America that specializes in the pharmaceutical and food industries.

About Us

For the past 30 years, Huayi has been collaborating with Peking University and Fudan University to advance medicine research. These investments have led to more than 30 project developments, including multiple medications considered to be first line treatments.

We believe our investments and contributions towards revolutionary medical technology will bring a healthier life to a diverse population.

Portfolio

Weiwei Group China

VV Food & Beverage Co., Ltd. was founded in 1994 and became a publicly traded company in 2000. It is a large-scale food manufacturing operation, receiving honorary titles

Shanghai Fosun Pharmaceutical

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (“Fosun Pharma”; stock code: 600196. SH, 02196. HK) is a global innovation-driven

The Derma

Announced the successful completion of the A-round financing of 100 million yuan, led by Bainuo Capital and followed by Betta Fund. Angel round investor Hankang Capital continued to add suppor

Zupan

Zupan makes inventory counting software that makes your life and business easier and more efficient. Never lose a day of business or sales again. Gone are the days of doing a count by pen and paper or clunky scanning hardware.

Beijing Huayi-shennong Medicine Science-technology Co Ltd

Beijing Huayi Shennong Pharmaceutical Technology Co., Ltd. was founded in June 2002 with the primary goal of researching and developing novel Chinese medicines.

Coordination Pharmaceuticals

Coordination Pharmaceuticals, Inc. (CPI), is a privately held immuno-oncology company founded to develop anticancer products that can address unmet medical needs and improve patient care.

our team

News and Media

First release｜Zedman Pharmaceutical announced the completion of the A-round financing of 100 million yuan, led by Bainuo Capital

The drug with Dr. Chen Genghui, a distinguished expert of the Chinese Federation of Overseas Chinese as the main inventor, was approved by the FDA for marketing

The original innovative drug was approved in the United States three years after it was launched in China Inventor Chen Genghui: Success is due to national support and encouragement

Huayi Partners is a privately owned venture capital firm based in China and North America that specializes in the pharmaceutical and food industries.

Quick Links

Our Portfolio

Contact Info

© 2023 Huayi Partners. All rights reserved.

This site is registered on wpml.org as a development site.